Anzeige
Mehr »
Montag, 21.07.2025 - Börsentäglich über 12.000 News
Foremost Clean Energy: Auf dem Weg zu großen Entdeckungen im Saudi-Arabien des Urans
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N6HF | ISIN: DK0061078425 | Ticker-Symbol: S7C
Frankfurt
18.07.25 | 15:29
0,087 Euro
+0,93 % +0,001
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
STENOCARE A/S Chart 1 Jahr
5-Tage-Chart
STENOCARE A/S 5-Tage-Chart

Aktuelle News zur STENOCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.05.Communiqué from the Annual General Meeting of STENOCARE2
08.05.Stenocare A/S: Interim report first quarter 2025101STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2025 - 31.03.2025. The report, which has not been...
► Artikel lesen
STENOCARE Aktie jetzt für 0€ handeln
02.05.Stenocare A/S: Medical Cannabis Made Permanent in Denmark: Major Milestone for Patients and STENOCARE127STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S ("Stenocare") is pleased to announce that the Danish Parliament has officially passed legislation to make Denmark's...
► Artikel lesen
22.04.Notice to Annual General Meeting in STENOCARE A/S1
03.04.ASTRUM 10-10 Ext Stenocare - verbesserte Bioverfügbarkeit mit neuem medizinischem Cannabisextrakt289Koblenz (ots) - Die ADREXpharma GmbH stellt einen neuen und verbesserten medizinischen Cannabisextrakt für die Behandlung von Patienten vor. Das neue Produkt heißt "ASTRUM 10-10 Ext Stenocare" und enthält...
► Artikel lesen
03.04.STENOCARE ASTRUM 10-10 Oil Product Approved for Reimbursement in Germany4
28.03.STENOCARE interview with Proinvestor.com - Annual Report 20241
27.03.STENOCARE A/S publishes Annual Report 20241
27.02.Stenocare A/S: Q4 and Annual Financial Statement Release 2024207STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2024 - 31.12.2024. The report, which has not been...
► Artikel lesen
14.02.STENOCARE - The innovative ASTRUM 10-10 product is now available for Australian patients1
29.01.STENOCARE A/S Embarks on Strategic Transformation with HQ Relocation and Cultivation Facility Exit1
27.01.First North Denmark: Stenocare A/S - admission to trading of new shares196New shares in Stenocare A/S will be admitted to trading on Nasdaq First North Growth Market Denmark as per 28 January 2025 due to completion of a rights issue. ISIN: DK0061078425 Name: Stenocare Number...
► Artikel lesen
22.01.STENOCARE A/S: Conditional Rights Issue subscribed to 45.0 percent1
02.01.XFRA CAPITAL ADJUSTMENT INFORMATION - 02.01.2025534Das Instrument S7C DK0061078425 STENOCARE DK-,08 EQUITY wird cum Kapitalmassnahme gehandelt am 02.01.2025 und ex Kapitalmassnahme am 03.01.2025 The instrument S7C DK0061078425 STENOCARE DK-,08 EQUITY...
► Artikel lesen
17.12.24Stenocare A/S: STENOCARE Gains Danish Approval for New Medical Cannabis CBD100 oil132STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO Stenocare has received approval from the Danish Medicines Agency to start selling a new medical cannabis oil product to Danish...
► Artikel lesen
05.11.24Stenocare A/S: Interim Report Third Quarter 2024204STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2024 - 30.09.2024. The report, which has not been reviewed...
► Artikel lesen
14.10.24Stenocare A/S: STENOCARE updates guidance for 2024161STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1